GlassScriptPhysician profile
Daniel Keith Roton
NPI 1679001002
$11,800.55
in general payments reported to CMS, 2019-2025
22 companies · $1,269 in 2025
The $1,269 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $88.53 · 2024: $10K · 2025: $1,269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,864 · Travel and Lodging: $3,695 · Food and Beverage: $2,226 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,864.04 |
| Travel and Lodging | $3,695.43 |
| Food and Beverage | $2,226.09 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,505.61 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $193.82 | 2024-2025 | Fasenra, Airsupra, Breztri |
| Regeneron Healthcare Solutions, INC. | $171.93 | 2024-2025 | Dupixent |
| Insmed, INC. | $140.29 | 2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.76 | 2023-2025 | Ofev, Jascayd |
| Glaxosmithkline, LLC. | $68.80 | 2025 | Trelegy Ellipta |
| Baxter Healthcare | $66.72 | 2025 | Hillrom - Monarch Airway Clearance System |
| Philips North America LLC | $62.19 | 2025 | Vest Therapy Und |
| Verona Pharma, INC. | $58.20 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $56.66 | 2024-2025 | Verquvo, Capvaxive |
| Galvanize Therapeutics, INC | $54.58 | 2025 | Aliya System |
| Bayer Healthcare Pharmaceuticals INC. | $45.26 | 2025 | |
| Viatris Specialty LLC | $42.91 | 2025 | Yupelri |
| Angiodynamics, INC. | $39.42 | 2025 | Alphavac |
| Monaghan Medical Corporation | $35.74 | 2025 | Aerochamber |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.78 | 2024-2025 | Lifevest |
| Genzyme Corporation | $30.40 | 2025 | |
| Electromed, INC. | $25.86 | 2025 | Smartvest |
| United Therapeutics Corporation | $19.58 | 2025 | Tyvaso |
| Novo Nordisk INC | $18.68 | 2025 | Wegovy |
| Novartis Pharmaceuticals Corporation | $15.06 | 2025 | |
| Tactile Systems Technology INC | $14.30 | 2025 | Nimbl, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Roton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.